Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / COMMON STOCK, PAR V ALUE $0.001 PER SHARE
-
Shares outstanding
-
74.9M
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
11.2M
-
Shares change
-
+231K
-
Total reported value, excl. options
-
$46.9M
-
Value change
-
+$1.43M
-
Put/Call ratio
-
4.41
-
Number of buys
-
21
-
Number of sells
-
-22
-
Price
-
$4.22
Significant Holders of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) as of Q4 2022
74 filings reported holding CRMD - CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE as of Q4 2022.
CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.2M shares
of 74.9M outstanding shares and own 14.89% of the company stock.
Largest 10 shareholders include NOMURA HOLDINGS INC (2.95M shares), VANGUARD GROUP INC (1.8M shares), Elliott Investment Management L.P. (1.55M shares), BlackRock Inc. (641K shares), MILLENNIUM MANAGEMENT LLC (582K shares), GEODE CAPITAL MANAGEMENT, LLC (357K shares), Cresset Asset Management, LLC (330K shares), BANK OF MONTREAL /CAN/ (287K shares), CITADEL ADVISORS LLC (193K shares), and Spinnaker Capital LLC (175K shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.